Skip to Content

Clenpiq Approval History

FDA Approved: Yes (First approved November 28, 2017)
Brand name: Clenpiq
Generic name: sodium picosulfate, magnesium oxide, and anhydrous citric acid
Dosage form: Oral Solution
Company: Ferring Pharmaceuticals Inc.
Treatment for: Bowel Preparation

Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) is a stimulant laxative and osmotic laxative combination indicated for cleansing of the colon as a preparation for colonoscopy.

Development History and FDA Approval Process for Clenpiq

DateArticle
Nov 29, 2017Approval FDA Approves Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide